Want to see ENDV full AI Analyst Report?

Endonovo Therapeutics (ENDV) Cash flow

24 Followers

Endonovo Therapeutics Cash Flow

ENDV's free cash flow for Q2 2026 was $-49.82K. For the 2026 fiscal year, ENDV's free cash flow was decreased by $-143.48K and operating cash flow was $-49.82K. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Mar 22
Operating Cash Flow	$ -42.99K	$ 100.49K	$ 121.87K	$ -678.84K	$ -986.58K
Investing Cash Flow	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Financing Cash Flow	$ 43.00K	$ -105.33K	$ -120.13K	$ 593.00K	$ 1.06M
End Cash Position	$ 12.00	$ 3.00	$ 1.84K	$ 98.00	$ 85.94K
Free Cash Flow	$ -42.99K	$ 100.49K	$ 121.87K	$ -678.84K	$ -986.58K

Currency in USD